drugset / Trial / NCT07526506
Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers
RandomizedSequentialDouble-blindTreatment
Summary
This is a Phase 1b, randomized, double-blind, placebo-controlled, dose escalation study of TRX-100 tablets evaluating the safety, pharmacokinetics, and food effect of single ascending doses of TRX-100 in healthy volunteers.
Timeline
- Start
- 2026-03-25
- Primary completion
- 2026-09
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TRX-100 | Unknown | 240 mg | — |
| Subject | TRX-100 | Unknown | 480 mg | — |
Indications
No indication recorded.